Sustained release dosage forms of ziprasidone

Details for Australian Patent Application No. 2004268663 (hide)

Owner Pfizer Products Inc.

Inventors Waterman, Kenneth C.; Herbig, Scott Max; Shamblin, Sheri L.; Smithey, Daniel Tod; Babcock, Walter Christian; Lyon, David Keith; Ahmed, Imran; Sutton, Steven C.; Shanker, Ravi Mysore; Thombre, Avinash Govind; Friesen, Dwayne Thomas; Appel, Leah Elizabeth

Agent Spruson & Ferguson

Pub. Number AU-B-2004268663

PCT Pub. Number WO2005/020929

Priority 60/499,484 02.09.03 US

Filing date 31 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 9 December 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/020929 Priority application(s): WO2005/020929

13 August 2009 Assignment before Grant

  Smithey, Daniel; Babcock, Walter; Ahmed, Imran; Thombre, Avinash; Shamblin, Sheri; Herbig, Scott; Appel, Leah; Friesen, Dwayne; Waterman, Kenneth; Lyon, David; Sutton, Steven; Shanker, Ravi The application has been assigned to Pfizer Products Inc.

9 December 2010 Application Accepted

  Published as AU-B-2004268663

7 April 2011 Standard Patent Sealed

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268665-Methods related to the treatment of mucosal associated conditions

2004268661-Novel drug compositions and dosage forms of topiramate